Colombia Viscosupplementation Market Size & Outlook
Colombia viscosupplementation market, 2018-2030 (US$M)
Related Markets
Colombia viscosupplementation market highlights
- The Colombia viscosupplementation market generated a revenue of USD 8.4 million in 2023 and is expected to reach USD 16.9 million by 2030.
- The Colombia market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, three injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 8.4 million |
| Market revenue in 2030 | USD 16.9 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Three injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Colombia accounted for 0.2% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 18.5 million by 2030.
Three injection was the largest segment with a revenue share of 44.05% in 2023. Horizon Databook has segmented the Colombia viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
There are several reports of the incidence and prevalence of osteoarthritis, with prevalence ranging from 0.5% to 36% in the general population. The prevalence and characteristics of osteoarthritis in Latin Americans are not completely known. Several studies from COPCORD (Community Oriented Program for the Control of Rheumatic Diseases) have shown that the prevalence of osteoarthritis ranges from 2.3% to 20.4% in different countries.
Use of NSAIDs, an analgesic such as paracetamol is the most common drug for treating osteoarthritis in Colombia with the highest usage percent of 62.1%. Use of viscosupplementation was found to be low in the region when compared with Mexico. A study conducted in Colombia showed a low prevalence of disease like osteoarthritis.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Colombia viscosupplementation market size, by product, 2018-2030 (US$M)
Colombia Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
